Karen Schorn
Rheumatology · West End, NCNPI 1710919683
Payments from drug & device makers
Across 480 payments — averaging $18.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$4K
- Johnson & Johnson$878
- AbbVie$702
- UCB, Inc.$640
- Regeneron Healthcare Solutions, Inc.$353
- GSK$335
- plus $2K from 18 others
What the payments were for
- Food & beverage$8,55699%
- Education$831%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 206 | $3,968 |
| Johnson & Johnson(2 entities) | 61 | $878 |
| AbbVie | 44 | $702 |
| UCB, Inc. | 32 | $640 |
| Regeneron Healthcare Solutions, Inc. | 23 | $353 |
| GSK | 22 | $335 |
| E.r. Squibb & Sons, L.L.C. | 21 | $278 |
| Novartis | 15 | $216 |
| Fresenius Kabi USA, LLC | 9 | $190 |
| Aurinia Pharma U.S., Inc. | 6 | $180 |
| Pfizer | 8 | $143 |
| AstraZeneca | 3 | $132 |
| Actelion Pharmaceuticals US, Inc. | 1 | $125 |
| Bristol Myers Squibb | 5 | $100 |
| Genentech USA, Inc. | 6 | $92 |
| Sandoz | 4 | $76 |
| Sanofi | 3 | $53 |
| Radius Health, Inc. | 3 | $50 |
| Boehringer Ingelheim | 2 | $38 |
| Lilly USA, LLC | 2 | $26 |
| Organon | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
| Pacira Therapeutics, Inc. | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,639 in reported general payments places this provider in the 60th percentile of 210 rheumatology providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 59 | $632,125 |
| Enbrel SureclickEtanercept | 25 | $194,372 |
| Orencia ClickjectAbatacept | 12 | $75,425 |
| Hydroxychloroquine Sulfate | 140 | $7,064 |
| Febuxostat | 14 | $1,629 |
| Mycophenolate Mofetil | 12 | $889 |
| MethotrexateMethotrexate Sodium | 38 | $871 |
| Leflunomide | 13 | $624 |
| Prednisone | 83 | $536 |
| Gabapentin | 26 | $362 |
| Allopurinol | 27 | $301 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in West End
- Laura SchanbergDurham$6.9M
- Rakesh PatelSalisbury$4M
- Jane BoxCharlotte$3.9M
- Gordon LamCharlotte$3.5M
- David SnowDelco$3.4M
- Alireza NamiCharlotte$3.1M
- Tauseef SyedGreensboro$1.7M
- Michael HershfieldDurham$1.5M
- Ralph SnydermanDurham$1.3M
- Megan ClowseDurham$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.